Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Amicus Therapeutics Inc. buy JPMorgan Chase & Co.

Amicus Therapeutics Inc.
Start price
€10.40
16.08.24 / 50%
Target price
€14.55
16.08.25
Performance (%)
-5.77%
Price
€9.70
20.09.24
Summary
This prediction is currently active. With a performance of -5.77%, the BUY prediction for Amicus Therapeutics Inc. by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 16.08.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Amicus Therapeutics Inc. -4.902% -4.902%
iShares Core DAX® 0.347% 2.173%
iShares Nasdaq 100 0.715% 0.138%
iShares Nikkei 225® 1.522% 2.003%
iShares S&P 500 0.631% 1.633%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Amicus Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -5.77%
Target price 14.549
Change
Ends at 16.08.25

Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at JPMorgan Chase & Co. from $17.00 to $16.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat

JPMorgan Chase & Co. 
0
Report Share
16.08.24

Stopped prediction by JPMorgan_Chase___Co_ for Amicus Therapeutics Inc.

buy
Amicus Therapeutics Inc.

Start price
Target price
Perf. (%)
€11.70
29.09.23
€17.92
29.09.24
-16.24%
20.09.24

JPMorgan Chase & Co. 
29.09.23 50%